Haemonetics's total assets for Q2 2026 were $2.44B, a decrease of -0.81% from the previous quarter. HAE total liabilities were $1.59B for the fiscal quarter, a 0.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.